8 Japan Drug Majors’ Combined Sales Rise 10.2% in FY2021 on Global Brands, Strong Offshore Presence Is Key to Further Growth

Eight leading Japanese drug makers recorded a two-digit growth in their combined sales in FY2021, driven by a robust performance of their flagship global brands, a Jiho tally showed. While reaping the benefits of the weaker yen, their profit was...read more